US7528168B2ExpiredUtilityPatentIndex 54
Inhibitors of the fatty acid oxidation for the prophylaxis and/or the treatment of chronic and/or atopic skin diseases
Est. expirySep 19, 2022(expired)· nominal 20-yr term from priority
A61P 17/06A61P 17/00A61K 31/336
54
PatentIndex Score
2
Cited by
10
References
6
Claims
Abstract
The invention relates to a method of preventing and/or treating a chronic and/or an atopic skin disease by administering an inhibitor of fatty acid oxidation to a patient in a pharmacologically effective amount. Furthermore, the invention relates to the use of at least one inhibitor of fatty acid oxidation for the preparation of a pharmaceutical composition for the prophylaxis and/or treatment of a chronic and/or an atopic skin disease.
Claims
exact text as granted — not AI-modified1. A method of treating psoriasis in a patient in need thereof by administering 2-(6-(4-chlorophenoxy)hexyl)oxirane-2-carboxylic acid ethyl ester (Etomoxir) to a patient in a pharmacologically effective amount.
2. The method according to claim 1 , wherein the patient is human.
3. The method according to claim 1 , wherein the 2-(6-(4-chlorophenoxy)hexyl)oxirane-2-carboxylic acid ethyl ester is administered topically.
4. The method according to claim 1 , wherein the 2-(6-(4-chlorophenoxy)hexyl)oxirane-2-carboxylic acid ethyl ester is administered together with at least one excipient and/or auxiliary.
5. The method according to claim 4 , wherein the excipient and/or auxiliary is selected from the group consisting of one or more suitable adjuvant(s), one or more pharmaceutically active and/or acceptable carrier(s), diluent(s), filler(s), binder(s), disintegrant(s), lubricant(s), glident(s), coloring agent(s), flavoring agent(s), opaquing agent(s) and plasticizer(s).
6. The method according to claim 4 , wherein the 2-(6-(4-chlorophenoxy)hexyl)oxirane-2-carboxylic acid ethyl ester is administered topically and the said at least one excipient and/or auxiliary is hydrophobic and is selected from the group consisting of petroleum jelly, wax, oleyl alcohol, propylene glycol monostearate, propylene glycol monopalmitostearate, isopropyl laureate, isopropyl myristate, isopropyl palmitate, isopropyl stearate, ethyl myristate, propyl myristate, butyl myristate, ethyl oleate, Cetylstearyl alcohol, lanolin alcohol and paraffin oil.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.